Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1975 May;7(5):640–645. doi: 10.1128/aac.7.5.640

Empiric Therapy for Cancer Patients: Comparative Study of Ticarcillin-Tobramycin, Ticarcillin-Cephalothin, and Cephalothin-Tobramycin

J Klastersky 1, C Hensgens 1, L Debusscher 1
PMCID: PMC429195  PMID: 1096809

Abstract

Three combinations of antibiotics (cephalothin-tobramycin, cephalothin-ticarcillin, and ticarcillin-tobramycin) were administered empirically to 186 patients with cancer who were suspected of having a life-threatening infection. In approximately one-half of these patients, gram-negative infection was documented bacteriologically and consisted of septicemia in 50% of these patients. The three antimicrobial regimens were similarly effective and resulted in a favorable clinical response in approximately 55% of the patients. The administration of the cephalothin-tobramycin combination was associated with a significantly higher frequency of nephrotoxicity than that of the other two regimens.

Full text

PDF
640

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodey G. P., Buckley M., Sathe Y. S., Freireich E. J. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966 Feb;64(2):328–340. doi: 10.7326/0003-4819-64-2-328. [DOI] [PubMed] [Google Scholar]
  2. Bodey G. P., Middleman E., Umsawadi T., Rodriguez V. Infections in cancer patients. Results with gentamicin sulfate therapy. Cancer. 1972 Jun;29(6):1697–1701. doi: 10.1002/1097-0142(197206)29:6<1697::aid-cncr2820290638>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  3. Fillastre J. P., Laumonier R., Humbert G., Dubois D., Metayer J., Delpech A., Leroy J., Robert M. Acute renal failure associated with combined gentamicin and cephalothin therapy. Br Med J. 1973 May 19;2(5863):396–397. doi: 10.1136/bmj.2.5863.396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Freid M. A., Vosti K. L. The importance of underlying disease in patients with gram-negative bacteremia. Arch Intern Med. 1968 May;121(5):418–423. [PubMed] [Google Scholar]
  5. Klastersky J., Cappel R., Daneau D. Clinical significance of in vitro synergism between antibiotics in gram-negative infections. Antimicrob Agents Chemother. 1972 Dec;2(6):470–475. doi: 10.1128/aac.2.6.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Klastersky J., Daneau D., Verhest A. Causes of death in patients with cancer. Eur J Cancer. 1972 Apr;8(2):149–154. doi: 10.1016/0014-2964(72)90036-9. [DOI] [PubMed] [Google Scholar]
  7. Klastersky J., Henri A., Hensgens C., Daneau D. Gram-negative infections in cancer. Study of empiric therapy comparing carbenicillin-cephalothin with and without gentamicin. JAMA. 1974 Jan 7;227(1):45–48. doi: 10.1001/jama.227.1.45. [DOI] [PubMed] [Google Scholar]
  8. Klastersky J., Henri A., Vandenborre L. Antimicrobial activity of tobramycin and gentamicin used in combination with cephalothin and carbenicillin. Am J Med Sci. 1973 Jul;266(1):13–21. doi: 10.1097/00000441-197307000-00002. [DOI] [PubMed] [Google Scholar]
  9. Klastersky J., Swings G., Vandenborre L., Weerts D., De Maertelaer V. Effectiveness of the carbenicillin-cephalothin combination against gram-negative bacilli. Am J Med Sci. 1973 Jan;265(1):45–53. doi: 10.1097/00000441-197301000-00004. [DOI] [PubMed] [Google Scholar]
  10. Levine A. S., Schimpff S. C., Graw R. G., Jr, Young R. C. Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. Semin Hematol. 1974 Apr;11(2):141–202. [PubMed] [Google Scholar]
  11. Middleman E. L., Watanabe A., Kaizer H., Bodey G. P. Antibiotic combinations for infections in neutropenic patients. Evaluaton of carbenicillin plus either cephalothin or kanamycin. Cancer. 1972 Aug;30(2):573–579. doi: 10.1002/1097-0142(197208)30:2<573::aid-cncr2820300238>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  12. Perry J. E., Cluff L. E. The effect of penicillin upon experimental lethal pneumococcal infection. Tex Rep Biol Med. 1966 Spring;24(1):141–152. [PubMed] [Google Scholar]
  13. Richards F., McCall C., Cox C. Gentamicin treatment of staphylococcal infections. JAMA. 1971 Feb 22;215(8):1297–1300. [PubMed] [Google Scholar]
  14. Schimpff S., Satterlee W., Young V. M., Serpick A. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med. 1971 May 13;284(19):1061–1065. doi: 10.1056/NEJM197105132841904. [DOI] [PubMed] [Google Scholar]
  15. Tattersall M. H., Spiers A. S., Darrell J. H. Initial therapy with combination of five antibiotics in febrile patients with leukaemia and neutropenia. Lancet. 1972 Jan 22;1(7743):162–165. doi: 10.1016/s0140-6736(72)90567-3. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES